First drug-resistant malaria parasite detected in Africa

February 22, 2017
Credit: CDC

For the first time in Africa, researchers said Wednesday they have detected a malaria parasite that is partially resistant to the top anti-malaria drug, artemisinin, raising concern about efforts to fight a disease that sickens hundreds of millions of people each year.

The discovery means that Africa now joins southeast Asia in hosting such drug-resistant forms of the mosquito-borne disease.

Malaria infected more than 200 million people and killed some 438,000 people worldwide in 2015, most of them children in Africa.

"The spread of artemisinin resistance in Africa would be a major setback in the fight against , as ACT (artemisinin-based ) is the only effective and widely used antimalarial treatment at the moment," said lead author Arnab Pain, professor at the King Abdullah University of Science and Technology.

"Therefore, it is very important to regularly monitor artemisinin resistance worldwide."

The drug-resistant malaria parasites were detected in a Chinese patient who had traveled from Equatorial Guinea to China, said the report led by Jun Cao from the Jiangsu Institute for Parasitic Diseases in China.

The study was published in the New England Journal of Medicine.

Combination therapy with artemisinin usually clears malaria from the blood in three days.

In southeast Asia, strains of the malaria-causing agent, Plasmodium falciparum, have grown relatively tolerant to artemisinin, in what is known as "partial resistance."

Most patients can still be cured, but it takes longer.

World Health Organization experts are concerned that P. falciparum could eventually become completely resistant to artemisinin, just as it has to other antimalarial drugs.

Researchers said they found the parasite carried a new mutation in a gene called Kelch13 (K13), which is the main driver for artemisinin resistance in Asia.

They then confirmed the origin of the was Africa, by using "whole-genome sequencing and bioinformatics tools we had previously developed—like detectives trying to link the culprit parasite to the crime scene," he said.

Explore further: Malaria superbugs threaten global malaria control

More information: New England Journal of Medicine, dx.doi.org/10.1056/NEJMc1612765

Related Stories

Malaria superbugs threaten global malaria control

February 1, 2017
A lineage of multidrug resistant P. falciparum malaria superbugs has widely spread and is now established in parts of Thailand, Laos and Cambodia, causing high treatment failure rates for the main falciparum malaria medicines, ...

Less effective antimalarial therapies can help fight malaria better

November 12, 2015
Oxford University scientists have found that the more effective way to beat malaria is to use less effective drugs some of the time.

Drug-resistant malaria strain contained in Asia: scientists

June 23, 2016
A parasite resistant to the top anti-malaria drug is confined to Southeast Asia and has not yet spread to sub-Saharan Africa as feared, said researchers Wednesday.

New genetic mutation could signal start of malaria drug resistance in Africa

April 17, 2015
Early indicators of the malaria parasite in Africa developing resistance to the most effective drug available have been confirmed, according to new research published in Antimicrobial Agents and Chemotherapy.

Drug-resistant malaria could spread to Africa: study

October 20, 2015
A drug-resistant malaria parasite from southeast Asia can infect African mosquitoes, said a study Tuesday, boosting fears that a hard-to-cure variant of the disease could reach the world's most vulnerable continent.

New hybrid drug plugs the hole in malaria drug resistance

April 11, 2016
A combination of artemisinin and another drug (artemisinin combination therapy, ACT) is currently the best malaria treatment recommended by the World Health Organization. In early 2015, artemisinin-resistant malaria was confirmed ...

Recommended for you

Study reveals new therapeutic target for slowing the spread of flu virus

June 22, 2018
Influenza A (flu A) hijacks host proteins for viral RNA splicing and blocking these interactions caused replication of the virus to slow, according to new research published in Nature Communications by Kristin W. Lynch, Ph.D., ...

First ancient syphilis genomes decoded

June 21, 2018
An international research team, including scientists from the Max Planck Institute for the Science of Human History, the University of Tübingen, the National School of Anthropology and History in Mexico City, and the University ...

Rhesus macaque model offers route to study Zika brain pathology

June 21, 2018
Rhesus macaque monkeys infected in utero with Zika virus develop similar brain pathology to human infants, according to a report by researchers at the California National Primate Research Center and School of Veterinary Medicine ...

California Aedes mosquitoes capable of spreading Zika

June 21, 2018
Over the last five years, Zika virus has emerged as a significant global human health threat following outbreaks in South and Central America. Now, researchers reporting in PLOS Neglected Tropical Diseases have shown that ...

Breakthrough treatment for crippling jaw disease created

June 20, 2018
A first-ever tissue implant to safely treat a common jaw defect, known as temporomandibular joint dysfunction, has been successfully tested by UCI-led researchers in a large animal model, according to new findings.

Cell-free DNA profiling informative way to monitor urinary tract infections

June 20, 2018
Using shotgun DNA sequencing, Cornell University researchers have demonstrated a new method for monitoring urinary tract infections (UTIs) that surpasses traditional methods in providing valuable information about the dynamics ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.